Association between the ratio of anti-angiogenic isoform of VEGF-A to total VEGF-A and adverse clinical outcomes in patients after acute myocardial infarction

Ferrara, 2003, The biology of VEGF and its receptors, Nat. Med., 9, 669, 10.1038/nm0603-669 Cochain, 2013, Angiogenesis in the infarcted myocardium, Antioxid. Redox Signal., 18, 1100, 10.1089/ars.2012.4849 Niu, 2016, Correlation between vascular endothelial growth factor and long-term prognosis in patients with acute myocardial infarction, Exp. Ther. Med., 12, 475, 10.3892/etm.2016.3286 Matsudaira, 2012, Group NAMISN. Impact of low levels of vascular endothelial growth factor after myocardial infarction on 6-month clinical outcome. Results from the Nagoya Acute Myocardial Infarction Study, Circ. J., 76, 1509, 10.1253/circj.CJ-11-1127 Neufeld, 1999, Vascular endothelial growth factor (VEGF) and its receptors, FASEB J., 13, 9, 10.1096/fasebj.13.1.9 Peiris-Pagès, 2012, The role of VEGF 165b in pathophysiology, Cell Adhes. Migr., 6, 561, 10.4161/cam.22439 Woolard, 2004, VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression, Cancer Res., 64, 7822, 10.1158/0008-5472.CAN-04-0934 Manetti, 2011, Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis, Circ. Res., 109, e14, 10.1161/CIRCRESAHA.111.242057 Suzuki, 2016, Association between levels of anti-angiogenic isoform of vascular endothelial growth factor A and pulmonary hypertension, Int. J. Cardiol., 222, 416, 10.1016/j.ijcard.2016.07.277 Kikuchi, 2014, An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease, Nat. Med., 20, 1464, 10.1038/nm.3703 Chu, 2016, A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF(165b) in peripheral arterial disease in human and mouse, Sci. Rep., 6, 37030, 10.1038/srep37030 Ganta, 2017, VEGF165b modulates endothelial VEGFR1-STAT3 signaling pathway and angiogenesis in human and experimental peripheral arterial disease, Circ. Res., 120, 282, 10.1161/CIRCRESAHA.116.309516 Hueso, 2017, Dynamics and implications of circulating anti-angiogenic VEGF-A165b isoform in patients with ST-elevation myocardial infarction, Sci. Rep., 7, 9962, 10.1038/s41598-017-10505-9 Latorre, 2018, The VEGFA156b isoform is dysregulated in senescent endothelial cells and may be associated with prevalent and incident coronary heart disease, Clin. Sci. (Lond.), 132, 313, 10.1042/CS20171556 Thygesen, 2012, Third universal definition of myocardial infarction, Circulation, 126, 2020, 10.1161/CIR.0b013e31826e1058 Dissmann, 1998, Estimation of enzymatic infarct size: direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase, Am. Heart J., 135, 1, 10.1016/S0002-8703(98)70335-7 Soeki, 2002, Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction, Circ. J., 66, 1003, 10.1253/circj.66.1003 Kranz, 2000, Elevation of vascular endothelial growth factor—a serum levels following acute myocardial infarction. Evidence for its origin and functional significance, J. Mol. Cell. Cardiol., 32, 65, 10.1006/jmcc.1999.1062 Heeschen, 2003, Investigators CcEA-PTiURa. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes, Circulation, 107, 524, 10.1161/01.CIR.0000048183.37648.1A Paine, 2017, Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy, Mol. Vis., 23, 356 Nahrendorf, 2010, Monocytes: protagonists of infarct inflammation and repair after myocardial infarction, Circulation, 121, 2437, 10.1161/CIRCULATIONAHA.109.916346 Schömig, 2000, N. Engl. J. Med., 343, 385, 10.1056/NEJM200008103430602 Keeley, 2003, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet, 361, 13, 10.1016/S0140-6736(03)12113-7 Tamura, 1999, Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction, Jpn. Circ. J., 63, 357, 10.1253/jcj.63.357